Together, these findings show that the IDH mutation status does not solely define the treatment response or outcome in chondrosarcoma patients, suggesting that the dichotomy between IDHWT and IDHMUT is also too simplistic for chondrosarcoma. Here, IDH2 is linked to chondrosarcoma.